For example, to target LDLR, Geninatti-Crich et al conjugated LDL with gadolinium/boron/ligand probes for more efficient delivery to HepG2 human liver cancer cells, B16 murine melanoma cells, and U87 human glioblastoma cells. This evidence concerns the gene LDLR and liver cancer.